CRL-40-941 – 60 capsules 50mg

CRL-40-941 50 mg is a research-grade wakefulness-promoting capsule formulation supplied in a convenient 60-capsule format. Also known as Fladrafinil or Bisfluoroadrafinil, CRL-40-941 is a synthetic compound structurally related to adrafinil and modafinil analogues. It is commonly investigated in experimental models involving wakefulness, vigilance, cognitive performance, dopaminergic signaling and sustained mental output. Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use. Purity High-purity research compound Form Capsules Content 50 mg CRL-40-941 per capsule Quantity 60 capsules per bottle Also known as Fladrafinil / Bisfluoroadrafinil Compound class Modafinil-related research compound Packaging Amber bottle with secure screw cap Storage Store in a cool, dry place. Protect from heat, moisture and direct light. Molecular formula C15H13F2N1O3S1 Molecular weight 325.33 g·mol⁻¹ CAS number 90212-80-9 CRL-40-941 is commonly investigated in laboratory models involving wakefulness, attention regulation and sustained cognitive performance. It is frequently referenced in research focused on dopaminergic transport systems, alertness pathways and central nervous system stimulation models. Research Overview CRL-40-941 (Fladrafinil) is a synthetic wakefulness-promoting research compound structurally related to the modafinil / adrafinil family. In experimental laboratory settings, it is used to investigate alertness, vigilance, mental endurance, neural activation and cognitive output under prolonged task demand. Preclinical literature and analogue-based research often examine its relationship to dopamine transporter activity, arousal systems and sustained wakefulness mechanisms. This product is supplied strictly for scientific and laboratory research purposes and is not intended to imply any therapeutic or medical application. Primary Research Areas Wakefulness & vigilance models: Experimental work focused on sustained alertness, attention stability and wake-promoting signaling systems. Cognitive endurance research: Laboratory models exploring prolonged mental output, task persistence and cognitive resilience under load. Dopaminergic signaling: Studies examining transporter-related mechanisms and central nervous system activation pathways. Modafinil-analogue comparison research: Comparative experimental frameworks evaluating structural and mechanistic similarities within wakefulness-promoting compound classes.